Header Logo

Connection

SALIM VIRANI to Risk Assessment

Back to Details
This is a "connection" page, showing publications SALIM VIRANI has written about Risk Assessment.
SALIM VIRANI
Connection Strength
7.428
Risk Assessment
  1. Recreational substance use among patients with premature atherosclerotic cardiovascular disease. Heart. 2021 04; 107(8):650-656.
    View in: PubMed
    Score: 0.358
  2. Effect of heart failure on the outcome of COVID-19 - A meta analysis and systematic review. Am J Emerg Med. 2021 Aug; 46:204-211.
    View in: PubMed
    Score: 0.343
  3. Very High-Risk ASCVD and Eligibility for Nonstatin Therapies Based on the 2018?AHA/ACC Cholesterol Guidelines. J Am Coll Cardiol. 2019 08 06; 74(5):712-714.
    View in: PubMed
    Score: 0.322
  4. Associations of Lipoprotein(a) Levels With Incident Atrial Fibrillation and Ischemic Stroke: The ARIC (Atherosclerosis Risk in Communities) Study. J Am Heart Assoc. 2017 Dec 15; 6(12).
    View in: PubMed
    Score: 0.287
  5. Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide. JAMA Cardiol. 2017 04 01; 2(4):361-369.
    View in: PubMed
    Score: 0.274
  6. From Plaque Burden to Plaque Composition: Toward?Personalized Risk?Assessment. JACC Cardiovasc Imaging. 2017 03; 10(3):250-252.
    View in: PubMed
    Score: 0.272
  7. Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry. J Am Coll Cardiol. 2015 Jan 20; 65(2):111-21.
    View in: PubMed
    Score: 0.235
  8. Relation between playing position and coronary artery calcium scores in retired National Football League players. Am J Cardiol. 2014 Dec 15; 114(12):1836-40.
    View in: PubMed
    Score: 0.230
  9. Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations: What Clinicians Need to Know? Curr Atheroscler Rep. 2025 Jul 21; 27(1):73.
    View in: PubMed
    Score: 0.122
  10. The Pandemic of Coronary Heart Disease in South Asia: What Clinicians Need to Know. Curr Atheroscler Rep. 2023 07; 25(7):359-372.
    View in: PubMed
    Score: 0.105
  11. Association of polygenic risk scores with incident atherosclerotic cardiovascular disease events among individuals with coronary artery calcium score of zero: The multi-ethnic study of atherosclerosis. Prog Cardiovasc Dis. 2022 Sep-Oct; 74:19-27.
    View in: PubMed
    Score: 0.099
  12. Association of premature atherosclerotic cardiovascular disease with higher risk of cancer: a behavioral risk factor surveillance system study. Eur J Prev Cardiol. 2022 Mar 25; 29(3):493-501.
    View in: PubMed
    Score: 0.097
  13. Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know. Prog Cardiovasc Dis. 2022 Jul-Aug; 73:32-40.
    View in: PubMed
    Score: 0.095
  14. The Utility of Coronary Artery Calcium for Guiding Treatment With Preventive Pharmacotherapy: Opportunities and Nuances. JACC Cardiovasc Imaging. 2022 04; 15(4):652-654.
    View in: PubMed
    Score: 0.095
  15. Association of Coronary Artery Calcium Density and Volume With Predicted Atherosclerotic Cardiovascular Disease Risk and Cardiometabolic Risk Factors in South Asians: The Mediators of Atherosclerosis in South Asians Living in America (MASALA) Study. Curr Probl Cardiol. 2023 Apr; 48(4):101105.
    View in: PubMed
    Score: 0.095
  16. A comparison of cardiovascular risk factors between Asian-Americans and non-Asian Americans: An analysis from the NHANES database. Prog Cardiovasc Dis. 2021 Sep-Oct; 68:94-96.
    View in: PubMed
    Score: 0.093
  17. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) guidelines for management of dyslipidemia and cardiovascular disease risk reduction: Putting evidence in context. Prog Cardiovasc Dis. 2021 Sep-Oct; 68:2-6.
    View in: PubMed
    Score: 0.093
  18. 2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2021 08 31; 78(9):960-993.
    View in: PubMed
    Score: 0.092
  19. Association Between Omega-3 Fatty Acid Treatment and Atrial Fibrillation in Cardiovascular Outcome Trials: A Systematic Review and Meta-Analysis. Cardiovasc Drugs Ther. 2021 08; 35(4):793-800.
    View in: PubMed
    Score: 0.091
  20. Premature Atherosclerotic Cardiovascular Disease Risk Among Patients with Inflammatory Bowel Disease. Am J Med. 2021 08; 134(8):1047-1051.e2.
    View in: PubMed
    Score: 0.090
  21. Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study. J Am Coll Cardiol. 2021 02 09; 77(5):559-571.
    View in: PubMed
    Score: 0.089
  22. Clinical characteristics and mortality after acute myocardial infarction-related hospitalization among Asians from a national population-based cohort study. Prog Cardiovasc Dis. 2021 Jul-Aug; 67:108-110.
    View in: PubMed
    Score: 0.089
  23. Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin-Associated Side Effects. J Am Heart Assoc. 2020 11 17; 9(22):e017915.
    View in: PubMed
    Score: 0.088
  24. Statin Prescription Rates, Adherence, and Associated Clinical Outcomes Among Women with PAD and ICVD. Cardiovasc Drugs Ther. 2020 12; 34(6):745-754.
    View in: PubMed
    Score: 0.087
  25. Premature Atherosclerotic Cardiovascular Disease: What Have We Learned Recently? Curr Atheroscler Rep. 2020 07 16; 22(9):44.
    View in: PubMed
    Score: 0.086
  26. High-Sensitivity C-Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study. J Am Heart Assoc. 2020 02 04; 9(3):e013600.
    View in: PubMed
    Score: 0.083
  27. Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation. 2020 03 03; 141(9):e139-e596.
    View in: PubMed
    Score: 0.083
  28. Spotlight on Icosapent Ethyl for Cardiovascular Risk Reduction: Evidence to Date. Vasc Health Risk Manag. 2020; 16:1-10.
    View in: PubMed
    Score: 0.083
  29. Effect of increasing age on percutaneous coronary intervention vs coronary artery bypass grafting in older adults with unprotected left main coronary artery disease: A meta-analysis and meta-regression. Clin Cardiol. 2019 Nov; 42(11):1071-1078.
    View in: PubMed
    Score: 0.081
  30. High-Sensitive Troponin T, Natriuretic Peptide, and Cognitive Change. J Am Geriatr Soc. 2019 11; 67(11):2353-2361.
    View in: PubMed
    Score: 0.080
  31. Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC study. Eur J Prev Cardiol. 2020 10; 27(15):1597-1605.
    View in: PubMed
    Score: 0.080
  32. The Interplay of the Global Atherosclerotic Cardiovascular Disease Risk Scoring and Cardiorespiratory Fitness for the Prediction of All-Cause Mortality and Myocardial Infarction: The Henry Ford ExercIse Testing Project (The FIT Project). Am J Cardiol. 2019 08 15; 124(4):511-517.
    View in: PubMed
    Score: 0.079
  33. 2018 Cholesterol Guidelines: Key Topics in Primary Prevention. Curr Atheroscler Rep. 2019 03 16; 21(5):17.
    View in: PubMed
    Score: 0.078
  34. Socio-economic inequalities in hypertension burden and cascade of services: nationwide cross-sectional study in Nepal. J Hum Hypertens. 2019 08; 33(8):613-625.
    View in: PubMed
    Score: 0.078
  35. Association of Body Mass Index With Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Cardiovascular Disease. Circ Cardiovasc Qual Outcomes. 2019 01; 12(1):e004817.
    View in: PubMed
    Score: 0.077
  36. Influence of Cardiovascular Risk Communication Tools and Presentation Formats on Patient Perceptions and Preferences. JAMA Cardiol. 2018 12 01; 3(12):1192-1199.
    View in: PubMed
    Score: 0.077
  37. Use of Risk Assessment Tools to?Guide?Decision-Making in the?Primary?Prevention of Atherosclerotic?Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2019 06 25; 73(24):3153-3167.
    View in: PubMed
    Score: 0.077
  38. Favorable Modifiable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs Among Cancer Patients: The 2012-2013 Medical Expenditure Panel Survey. J Am Heart Assoc. 2018 04 23; 7(9).
    View in: PubMed
    Score: 0.074
  39. Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012-2013 Medical Expenditures Panel?Survey. J Am Heart Assoc. 2017 Jun 09; 6(6).
    View in: PubMed
    Score: 0.069
  40. BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study. Int J Cardiol. 2017 Apr 15; 233:61-66.
    View in: PubMed
    Score: 0.068
  41. Harder-to-Treat Patients: Recognizing Them and Adapting Treatment Strategies. Am J Cardiol. 2016 Sep 15; 118(6 Suppl):13A-8A.
    View in: PubMed
    Score: 0.066
  42. The 2013 ACC/AHA Cholesterol Management Guideline: Clearing the Confusion from Noncontroversial Components. Tex Heart Inst J. 2016 Aug; 43(4):313-4.
    View in: PubMed
    Score: 0.065
  43. Cardiovascular disease risk by assigned treatment using the 2013 and 1998 obesity guidelines. Obesity (Silver Spring). 2016 07; 24(7):1554-60.
    View in: PubMed
    Score: 0.064
  44. The impact of multiple single day blood pressure readings on cardiovascular risk estimation: The Atherosclerosis Risk in Communities study. Eur J Prev Cardiol. 2016 09; 23(14):1529-36.
    View in: PubMed
    Score: 0.063
  45. Case-based educational intervention to assess change in providers' knowledge and attitudes towards the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline. Atherosclerosis. 2016 Mar; 246:115-20.
    View in: PubMed
    Score: 0.063
  46. Trends in Ideal Cardiovascular Health Metrics Among Employees of a Large Healthcare Organization (from the Baptist Health South Florida Employee Study). Am J Cardiol. 2016 Mar 01; 117(5):787-93.
    View in: PubMed
    Score: 0.063
  47. Case report: a lead you can't miss: a case of right ventricular perforation. Methodist Debakey Cardiovasc J. 2015 Jan-Mar; 11(1):51-2.
    View in: PubMed
    Score: 0.059
  48. High-sensitivity troponin T and cardiovascular events in systolic blood pressure categories: atherosclerosis risk in communities study. Hypertension. 2015 Jan; 65(1):78-84.
    View in: PubMed
    Score: 0.058
  49. Acute coronary syndromes: unstable angina and non-ST elevation myocardial infarction. Cardiol Clin. 2014 Aug; 32(3):353-70.
    View in: PubMed
    Score: 0.057
  50. Statins in the primary and secondary prevention of cardiovascular disease in women: facts and myths. Tex Heart Inst J. 2013; 40(3):288-9.
    View in: PubMed
    Score: 0.051
  51. Association between traditional cholesterol parameters, lipoprotein particle concentration, novel biomarkers and carotid plaques in retired National Football League players. Atherosclerosis. 2012 Jun; 222(2):551-6.
    View in: PubMed
    Score: 0.048
  52. Chromosome 9p21 single nucleotide polymorphisms are not associated with recurrent myocardial infarction in patients with established coronary artery disease. Circ J. 2012; 76(4):950-6.
    View in: PubMed
    Score: 0.048
  53. Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) carotid MRI study. Atherosclerosis. 2011 Dec; 219(2):596-602.
    View in: PubMed
    Score: 0.046
  54. Isolated coronary artery bypass grafting in obese individuals: a propensity matched analysis of outcomes. Circ J. 2011; 75(6):1378-85.
    View in: PubMed
    Score: 0.045
  55. Non-HDL cholesterol as a metric of good quality of care: opportunities and challenges. Tex Heart Inst J. 2011; 38(2):160-2.
    View in: PubMed
    Score: 0.044
  56. Preoperative statin therapy decreases risk of postoperative renal insufficiency. Cardiovasc Ther. 2010 Apr; 28(2):80-6.
    View in: PubMed
    Score: 0.042
  57. Obesity: an independent predictor of in-hospital postoperative renal insufficiency among patients undergoing cardiac surgery? Tex Heart Inst J. 2009; 36(6):540-5.
    View in: PubMed
    Score: 0.039
  58. Novel markers of inflammation in atherosclerosis. Curr Atheroscler Rep. 2008 Apr; 10(2):164-70.
    View in: PubMed
    Score: 0.037
  59. How to identify patients with vulnerable plaques. Diabetes Obes Metab. 2008 Sep; 10(10):824-33.
    View in: PubMed
    Score: 0.036
  60. Visit-to-visit lipid variability, coronary artery calcification, inflammation, and mortality in the Multi-Ethnic Study of Atherosclerosis. Eur J Prev Cardiol. 2025 Sep 22; 32(13):1235-1244.
    View in: PubMed
    Score: 0.031
  61. Global Sociodemographic Disparities in Ischemic Heart Disease Mortality According to Sex, 1980 to 2021. Circ Cardiovasc Qual Outcomes. 2025 Jul; 18(7):e011648.
    View in: PubMed
    Score: 0.030
  62. Early-onset atherosclerotic cardiovascular disease. Eur J Prev Cardiol. 2025 Jan 27; 32(2):100-112.
    View in: PubMed
    Score: 0.029
  63. A novel machine learning-based cancer-specific cardiovascular disease risk score among patients with breast, colorectal, or lung cancer. JNCI Cancer Spectr. 2025 Jan 03; 9(1).
    View in: PubMed
    Score: 0.029
  64. Clonal hematopoiesis of indeterminate potential and cardiovascular disease: Pathogenesis, clinical presentation, and future directions. Prog Cardiovasc Dis. 2024 Sep-Oct; 86:79-85.
    View in: PubMed
    Score: 0.029
  65. Predictors of incident stroke among individuals without coronary artery calcification: A pooled cohort analysis from the Multi-Ethnic Study of Atherosclerosis, Jackson Heart Study, and Framingham Heart Study. Vasc Med. 2024 12; 29(6):632-639.
    View in: PubMed
    Score: 0.029
  66. Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association. J Clin Lipidol. 2024 Sep-Oct; 18(5):e647-e663.
    View in: PubMed
    Score: 0.029
  67. Comparing Cardiovascular Risk Classification of U.S. Adults According to Pooled Cohort Equations and PREVENT Equations: Cross-Sectional Analysis of the National Health and Nutrition Examination Survey. Ann Intern Med. 2024 Oct; 177(10):1444-1448.
    View in: PubMed
    Score: 0.029
  68. Trajectory of C-Reactive Protein and Incident Heart Failure in Black Adults: The Jackson Heart Study. Circ Heart Fail. 2024 Aug; 17(8):e011199.
    View in: PubMed
    Score: 0.028
  69. Interaction between risk factors, coronary calcium, and CCTA plaque characteristics in patients aged 18-45 years. Eur Heart J Cardiovasc Imaging. 2024 Jul 31; 25(8):1071-1082.
    View in: PubMed
    Score: 0.028
  70. Global burden of cardiovascular disease attributable to smoking, 1990-2019: an analysis of the 2019 Global Burden of Disease Study. Eur J Prev Cardiol. 2024 Jul 23; 31(9):1123-1131.
    View in: PubMed
    Score: 0.028
  71. Presentation, management, and early outcomes of young acute coronary syndrome patients- analysis of 23,560 South Asian patients from 2012 to 2021. BMC Cardiovasc Disord. 2024 07 19; 24(1):378.
    View in: PubMed
    Score: 0.028
  72. Association of High-Density Lipoprotein Parameters and Risk of Heart?Failure: A Multicohort Analysis. JACC Heart Fail. 2024 Jul; 12(7):1242-1253.
    View in: PubMed
    Score: 0.028
  73. What is the additive value of nutritional deficiency to VA-FI in the risk assessment for heart failure patients? J Nutr Health Aging. 2024 Jul; 28(7):100253.
    View in: PubMed
    Score: 0.028
  74. Cardiovascular Health and Disease in the Pakistani American Population. Curr Atheroscler Rep. 2024 06; 26(6):205-215.
    View in: PubMed
    Score: 0.028
  75. Epidemiology and Prognostic Implications of Coronary Artery Calcium in Asymptomatic Individuals With Prediabetes: A Multicohort Study. Diabetes Care. 2024 Apr 01; 47(4):698-706.
    View in: PubMed
    Score: 0.028
  76. Association of cardiovascular health with subclinical coronary atherosclerosis progression among five racial and ethnic groups: The MASALA and MESA studies. Atherosclerosis. 2024 05; 392:117522.
    View in: PubMed
    Score: 0.028
  77. Development and Validation of the American Heart Association's PREVENT Equations. Circulation. 2024 02 06; 149(6):430-449.
    View in: PubMed
    Score: 0.027
  78. Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association. Circulation. 2023 12 12; 148(24):1982-2004.
    View in: PubMed
    Score: 0.027
  79. Interplay Between Zero CAC, Quantitative Plaque Analysis, and Adverse Events in a Diverse Patient Cohort. Circ Cardiovasc Imaging. 2023 08; 16(8):e015236.
    View in: PubMed
    Score: 0.027
  80. Age-Related Differences in the Contribution of Systolic Blood Pressure and Biomarkers to Cardiovascular Disease Risk Prediction: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Cardiol. 2023 10 01; 204:295-301.
    View in: PubMed
    Score: 0.027
  81. Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society. Atherosclerosis. 2023 06; 374:107-120.
    View in: PubMed
    Score: 0.026
  82. Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors: The Multi-Ethnic Study of Atherosclerosis. JAMA Cardiol. 2021 10 01; 6(10):1161-1170.
    View in: PubMed
    Score: 0.023
  83. Cardiovascular Disease Risk-Based Statin Utilization and Associated Outcomes in a Primary Prevention Cohort: Insights From a Large Health Care Network. Circ Cardiovasc Qual Outcomes. 2021 09; 14(9):e007485.
    View in: PubMed
    Score: 0.023
  84. Scope and Social Determinants of Food Insecurity Among Adults With Atherosclerotic Cardiovascular Disease in the United States. J Am Heart Assoc. 2021 08 17; 10(16):e020028.
    View in: PubMed
    Score: 0.023
  85. Social media and predictive analysis regarding dietary approaches to stop hypertension. Prog Cardiovasc Dis. 2021 Sep-Oct; 68:88-90.
    View in: PubMed
    Score: 0.023
  86. Transatlantic guidelines on dyslipidemia and cardiovascular risk: key differences across the pond. Curr Opin Endocrinol Diabetes Obes. 2021 04 01; 28(2):114-121.
    View in: PubMed
    Score: 0.023
  87. Patient-Perceived Versus Actual Risk of Cardiovascular Disease and Associated Willingness to Consider and Use Prevention Therapy. Circ Cardiovasc Qual Outcomes. 2021 01; 14(1):e006548.
    View in: PubMed
    Score: 0.022
  88. Revascularization Practices and Outcomes in Patients With Multivessel Coronary Artery Disease Who Presented With Acute Myocardial Infarction and Cardiogenic Shock in the US, 2009-2018. JAMA Intern Med. 2020 10 01; 180(10):1317-1327.
    View in: PubMed
    Score: 0.022
  89. Temporal Trends in Percutaneous Coronary?Intervention and Coronary Artery Bypass Grafting: Insights From the Washington Cardiac Care Outcomes Assessment Program. J Am Heart Assoc. 2020 06 02; 9(11):e015317.
    View in: PubMed
    Score: 0.021
  90. Burden and Consequences of Financial Hardship From Medical Bills Among Nonelderly Adults With Diabetes Mellitus in the United States. Circ Cardiovasc Qual Outcomes. 2020 02; 13(2):e006139.
    View in: PubMed
    Score: 0.021
  91. Association Between Poverty and Appropriate Statin Prescription for the Treatment of Hyperlipidemia in the United States: An Analysis From the ACC NCDR PINNACLE Registry. Cardiovasc Revasc Med. 2020 08; 21(8):1016-1021.
    View in: PubMed
    Score: 0.021
  92. Absence of Coronary Artery Calcification in Middle-Aged Familial Hypercholesterolemia Patients Without Atherosclerotic Cardiovascular Disease. JACC Cardiovasc Imaging. 2020 04; 13(4):1090-1092.
    View in: PubMed
    Score: 0.021
  93. Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program. Circ Cardiovasc Qual Outcomes. 2019 11; 12(11):e005455.
    View in: PubMed
    Score: 0.020
  94. Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry. J Am Heart Assoc. 2019 10; 8(19):e013229.
    View in: PubMed
    Score: 0.020
  95. Sex Differences in the Use of Statins in Community Practice. Circ Cardiovasc Qual Outcomes. 2019 08; 12(8):e005562.
    View in: PubMed
    Score: 0.020
  96. Risk Assessment of Stroke in Patients with Atrial Fibrillation: Current Shortcomings and Future Directions. Cardiovasc Drugs Ther. 2019 02; 33(1):105-117.
    View in: PubMed
    Score: 0.019
  97. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task?Force?on?Clinical Practice Guidelines. J Am Coll Cardiol. 2019 06 25; 73(24):3168-3209.
    View in: PubMed
    Score: 0.019
  98. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task?Force?on?Clinical Practice Guidelines. J Am Coll Cardiol. 2019 06 25; 73(24):e285-e350.
    View in: PubMed
    Score: 0.019
  99. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 06 18; 139(25):e1046-e1081.
    View in: PubMed
    Score: 0.019
  100. Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology. Circulation. 2019 06 18; 139(25):e1162-e1177.
    View in: PubMed
    Score: 0.019
  101. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 06 18; 139(25):e1082-e1143.
    View in: PubMed
    Score: 0.019
  102. Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Heart Assoc. 2018 06 13; 7(12).
    View in: PubMed
    Score: 0.019
  103. Life's Simple 7 and the risk of atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2018 08; 275:174-181.
    View in: PubMed
    Score: 0.019
  104. Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice: Insights From the PALM (Patient and Provider Assessment of Lipid Management) Registry. Circ Cardiovasc Qual Outcomes. 2018 03; 11(3):e004249.
    View in: PubMed
    Score: 0.018
  105. Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation. 2018 03 20; 137(12):e67-e492.
    View in: PubMed
    Score: 0.018
  106. Persistent socioeconomic disparities in cardiovascular risk factors and health in the United States: Medical Expenditure Panel Survey 2002-2013. Atherosclerosis. 2018 02; 269:301-305.
    View in: PubMed
    Score: 0.018
  107. Clinical pharmacist understanding of the 2013 American College of Cardiology/American Heart Association cholesterol guideline. J Clin Lipidol. 2018 Mar - Apr; 12(2):367-374.e3.
    View in: PubMed
    Score: 0.018
  108. Favorable cardiovascular risk factor profile is associated with lower healthcare expenditure and resource utilization among adults with diabetes mellitus free of established cardiovascular disease: 2012 Medical Expenditure Panel Survey (MEPS). Atherosclerosis. 2017 03; 258:79-83.
    View in: PubMed
    Score: 0.017
  109. Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease. JAMA Cardiol. 2017 01 01; 2(1):47-54.
    View in: PubMed
    Score: 0.017
  110. Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC study. Eur J Prev Cardiol. 2017 04; 24(6):628-638.
    View in: PubMed
    Score: 0.017
  111. Antihypertensive adherence and outcomes among community-dwelling Medicare beneficiaries: the Atherosclerosis Risk in Communities Study. J Eval Clin Pract. 2018 02; 24(1):48-55.
    View in: PubMed
    Score: 0.017
  112. Favorable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs and Resource Utilization: The 2012 Medical Expenditure Panel Survey. Circ Cardiovasc Qual Outcomes. 2016 Mar; 9(2):143-53.
    View in: PubMed
    Score: 0.016
  113. Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry. J Am Coll Cardiol. 2014 Dec 02; 64(21):2183-92.
    View in: PubMed
    Score: 0.015
  114. One-year outcomes associated with using observation services in triaging patients with nonspecific chest pain. Clin Cardiol. 2014 Oct; 37(10):591-6.
    View in: PubMed
    Score: 0.014
  115. Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study. Arterioscler Thromb Vasc Biol. 2014 May; 34(5):1069-77.
    View in: PubMed
    Score: 0.014
  116. Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the ARIC study. Eur J Prev Cardiol. 2014 Jul; 21(7):866-75.
    View in: PubMed
    Score: 0.013
  117. A genetic risk score based on direct associations with coronary heart disease improves coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC), but not in the Rotterdam and Framingham Offspring, Studies. Atherosclerosis. 2012 Aug; 223(2):421-6.
    View in: PubMed
    Score: 0.012
  118. Subclinical changes in serum creatinine and mortality after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2012 Mar; 143(3):682-688.e1.
    View in: PubMed
    Score: 0.012
  119. Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study. J Am Coll Cardiol. 2009 Dec 15; 54(25):2388-95.
    View in: PubMed
    Score: 0.010
  120. Lipid management: considerations in acute coronary syndrome. Curr Cardiol Rep. 2008 Jul; 10(4):334-41.
    View in: PubMed
    Score: 0.009
  121. Noncardiac surgery following percutaneous coronary intervention. Catheter Cardiovasc Interv. 2004 Nov; 63(3):267-73.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.